SOW
MDGL icon

State of Wyoming’s Madrigal Pharmaceuticals MDGL Stock Holding History

State of Wyoming’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
+2,410
New +$1.23M 0.13% 85
2022
Q3 		– Sell
-128
Closed -$9K – 1765
2022
Q2 		$9K Buy
128
+31
+32% +$2.28K 0.01% 1656
2022
Q1 		$10K Buy
97
+16
+20% +$1.35K 0.01% 1603
2021
Q4 		$7K Sell
81
-4
-5% -$329 ﹤0.01% 1697
2021
Q3 		$7K Sell
85
-41
-33% -$3.54K ﹤0.01% 1064
2021
Q2 		$12K Buy
126
+67
+114% +$7.93K 0.01% 994
2021
Q1 		$7K Buy
+59
New +$6.88K 0.01% 420

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State of Wyoming's MDGL Position: Q2 2026 in Review

State of Wyoming opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 2,410 shares worth $1.29M. The stake represents 0.13% of the portfolio and ranks #85 among its holdings. This is a return to the name: State of Wyoming previously reported a position in MDGL as recently as Q2 2022.

State of Wyoming first reported a position in MDGL in Q1 2021 and has held it in 7 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • State of Wyoming held 2,410 shares of Madrigal Pharmaceuticals worth $1.29M as of Q2 2026.
  • Madrigal Pharmaceuticals was a new State of Wyoming position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.13% of State of Wyoming's portfolio in Q2 2026, its #85 holding.
  • State of Wyoming first reported a position in Madrigal Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.